DR ASHUTOSH KUMAR ARYA
- Last Updated On :
DR ASHUTOSH KUMAR ARYA
Assistant Professor (Endocrine Biochemistry)
Department of Endocrinology and Metabolism,
All India Institute of Medical Sciences (AIIMS)
Ansari Nagar, New Delhi
Office no: 011-26549120; (Ext) 8040
Email id: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए. ; यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.
Office Address: Room no 7002, 7th Floor Convergence Block, Department of Endocrinology and Metabolism, AIIMS, New Delhi
Research profile
https://scholar.google.com/citations?user=02cMy-wAAAAJ&hl=en
https://www.researchgate.net/profile/Ashutosh-Arya-2?ev=hdr_xprf
https://www.linkedin.com/in/ashutosh-kumar-arya-phd-a6250548/
Employment Details
30th Nov 2022 onwards, Assistant Professor (Endocrine Biochemistry); Department of Endocrinology and Metabolism, AIIMS New Delhi
March 2022 to Nov 2022, Scientist -II (Proteomics), Centralized Core Research Facility (CCRF), AIIMS New Delhi
Aug 2017- July 2019, Senior Demonstrator (Contractual), Central Sophisticated Instrument Cell (CSIC), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh
Educational Details and Training
|
Degree/Training |
Field/Subjects |
University/Institute |
Year |
|
Research Associate |
--- |
Department of Endocrinology, PGIMER Chandigarh |
Aug 2019-Feb 2022 |
|
PhD |
Molecular Endocrinology |
PGIMER Chandigarh |
2017 |
|
M.Sc. |
Biochemistry |
University of Hyderabad, Hyderabad |
2009 |
|
B.Sc. (Hons) |
Botany (H), Zoology, Chemistry |
Banaras Hindu University (BHU), Varanasi |
2007 |
Research Interests
Endocrine Tumor Biology and Molecular Medicine Laboratory
My primary research focuses on OMICS-driven biomarker discovery for endocrine tumors, particularly parathyroid tumors, Multiple Endocrine Neoplasia (MEN) Syndrome, and Pheochromocytomas and Paragangliomas (PPGLs). Our research aims to enhance pathophysiology, diagnosis and treatment of endocrine tumors using wet-lab genomics, epigenomics, and proteomics approaches, and molecular biology techniques.
We currently have two funded projects: the first focuses on exploring the genomic landscape of MEN1 syndrome patients and their family members to develop an optimal diagnostic method. The second project involves the genomic clustering of PPGL patients and the identification of cluster-specific protein biomarkers.
Current Lab Members
Dr Mahak Garg, Project Research Scientist
Ms. Annu, Technical Support
Positions available: We are actively seeking candidates for PhD positions who have qualified for JRF exam conducted by CSIR-UGC/ICMR/DBT. If you are interested in working on OMICS-driven precision endocrinology projects or have a unique idea for collaboration, please connect with us via email.
Membership
Life member of Endocrine Society of India
Life member of Proteomics Society of India
Life member of Indian Society for Bone and Mineral Research
Member of Endocrine Society (USA)
Selected Recent Publications
https://pubmed.ncbi.nlm.nih.gov/?term=Arya+Ashutosh&sort=date
1. Garg R, Bhatt M, Arya AK, Jyotsna VP, Khadgawat R. Two families, two pathways: a case series of 46, XY DSD with 17α-hydroxylase deficiency and isolated 17,20-lyase deficiency due to novel CYB5A variant. J Pediatr Endocrinol Metab. 2025;38(6):649-657.
2. Kumari P, Garg S, Arya AK, et al. Enhancer of zeste homolog 2 (EZH2) in endocrine tumors: current knowledge and future directions. Expert Opin Ther Targets. 2025;29(3):159-169.
3. Arya AK, Kumari P, Singh P, Bhadada SK. Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis. Best Pract Res Clin Endocrinol Metab. 2025;39(2):101985.
4. Mukherjee S, Arya AK, Bhadada SK, et al. Characterization of primary hyperparathyroidism based on target organ involvement: An analysis from the Indian PHPT registry. Clin Endocrinol (Oxf). 2023;99(2):158-164.
5. Arya AK, Bhadada SK, Kumari P, et al. Differences in Primary Hyperparathyroidism Between Pre- and Postmenopausal Women in India. Endocr Pract. 2021;27(7):710-715.
6. Arya AK., Kumari, P., Bhadada, S.K. et al. Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry. J Bone Miner Metab. 2021;39, 253–259.
7. Singh P, Bhadada SK, Dahiya D, Arya AK, Saikia UN, Sachdeva N, Kaur J, Brandi ML, Rao SD. Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas. J Clin Endocrinol Metab. 2020;105(9):3015-3024.
8. Singh A, Mia MM, Cibi DM, Arya AK, Bhadada SK, Singh MK. Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice. J Biol Chem. 2019;294(21):8336-8347.
9. Arya AK, Bhadada SK, Singh P, et al. Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples. J Endocrinol Invest. 2019;42(5):577-59
10. Bhadada SK, Arya AK, Mukhopadhyay S, et al. Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab. 2018;36(2):238-245.




